168 related articles for article (PubMed ID: 3160957)
1. [The history of quinolines].
Wolffers I
Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
[No Abstract] [Full Text] [Related]
2. [Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: SMON].
Igata A
Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2302-3. PubMed ID: 12373837
[No Abstract] [Full Text] [Related]
3. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
4. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
Oakley GP
JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
[No Abstract] [Full Text] [Related]
5. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
Tjälve H
Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
[TBL] [Abstract][Full Text] [Related]
6. Chinese acupuncture treatment for SMON patients.
Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
[No Abstract] [Full Text] [Related]
7. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
8. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
Hanakago R; Uono M
Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
[TBL] [Abstract][Full Text] [Related]
9. SMON and other socially induced diseases in Japan.
Sonoda K
Soc Sci Med (1967); 1978 Nov; 12(6A):497-506. PubMed ID: 153585
[No Abstract] [Full Text] [Related]
10. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
Shigematsu I
Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
[No Abstract] [Full Text] [Related]
11. Data on clioquinol and S.M.O.N.
Lee JA
Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80663
[No Abstract] [Full Text] [Related]
12. Data on clioquinol and S.M.O.N.
Shigematsu I; Yanagawa H
Lancet; 1978 Oct; 2(8096):945. PubMed ID: 81960
[No Abstract] [Full Text] [Related]
13. Idiosyncratic neurotoxicity: clioquinol and bismuth.
Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
[No Abstract] [Full Text] [Related]
14. [Neurotoxicity of chinoform].
Iwashita H
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
[No Abstract] [Full Text] [Related]
15. Sub-acute myelo-optico neuropathy (a case report).
Mathew R; Gupta PS
J Assoc Physicians India; 1978 Jun; 26(6):547-8. PubMed ID: 152755
[No Abstract] [Full Text] [Related]
16. Clioquinol and S.M.O.N.: Reanalysis of original data.
Asao M
Lancet; 1979 Feb; 1(8113):446. PubMed ID: 84300
[No Abstract] [Full Text] [Related]
17. Oxyquinoline toxicity.
Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
[No Abstract] [Full Text] [Related]
18. [Neurotoxic symptoms following clioquinol (Enterovioform)].
Pannekoek JH
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
[No Abstract] [Full Text] [Related]
19. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
20. Clioquinol.
Bernard G; Griffith RW
Lancet; 1977 Apr; 1(8018):956. PubMed ID: 67419
[No Abstract] [Full Text] [Related]
[Next] [New Search]